AET USA 2025 x KACTUS

By Hannah Flaherty

December 2, 2025

We are excited to announce our participation in Antibody Engineering & Therapeutics (AET) USA 2025, happening in San Diego from December 14–17, 2025. This premier event is dedicated to advancing antibody discovery, engineering, and therapeutics — spanning bispecific and multispecific formats, ADCs, protein therapeutics, AI-driven design, immuno-oncology, and more. The 2025 edition features a globally recognized roster of antibody scientists and industry leaders, with a broad program of sessions, workshops, poster presentations, and vendor exhibits. 

What is Antibody Engineering & Therapeutics USA?

The Antibody Engineering & Therapeutics (AET) conference is a premier annual event that brings together scientists, researchers, and industry professionals from biotechnology and pharmaceutical sectors to explore advancements in antibody-based therapeutics. This conference focuses on cutting-edge research, innovation, and development strategies in antibody engineering, bispecifics, antibody-drug conjugates (ADCs), immune-oncology, and more.

Event Overview 

Venue: Marriott Marquis San Diego, 333 W Harbor Dr, San Diego, CA 92101

Dates: December 15-18, 2024

  • Conference Day 1: Sunday, December 14, 2025, 9:00 AM – 5:00 PM

  • Conference Day 2: Monday, December 15, 2025, 8:00 AM – 6:15 PM

    • Exhibit Hall Show Hours: 4:00PM-7:45PM

  • Conference Day 3: Tuesday, December 16, 2025, 7:30 AM – 7:15 PM

    • Exhibit Hall Show Hours:  9:45AM-7:15PM

  • Conference Day 4: Wednesday, December 17, 2025, 7:30 AM – 5:45 PM

    • Exhibit Hall Show Hours: 9:45AM-2:10PM

Booth #311

Event Schedule 

The Antibody Engineering & Therapeutics (AET) USA 2025 agenda features four days of keynotes, expert-led sessions, and interactive panels covering AI-driven antibody discovery, bispecifics and multispecifics, ADCs, targeted protein degradation, and immuno-oncology. Explore the full AET USA 2025 agenda for details.

Day 1: Sunday, December 14, 2025

  • Pre-Conference Training Course from 9:00 AM to 5:00 PM

  • Workshop 1 from 1:00 PM to 5:00 PM

  •  Workshop 2 from 1:00 PM to 5:00 PM

Day 2: Monday, December 15, 2025

  • Registration & Breakfast from 7:00 AM to 8:00 AM

  • Keynote Presentations from 8:00 AM to 12:10 PM

  • Scientific Luncheon Briefings from 12:15 PM to 1:15 PM

  • Afternoon Scientific Sessions & Tracks 1 & 2 from 2:25 PM to 3:45 PM

  • Networking Break & Exhibit Hall Opening at 4:00 PM

  • Evening Sessions from 4:45 PM to 5:45 PM

  • Opening Night Networking Reception from 6:15 PM to 7:45 PM

Day 3: Tuesday, December 16, 2025

  • Fun Run at 6:30 AM

  • Registration at 7:15 AM

  • Scientific Breakfast Briefings at 7:30 AM

  • Morning Sessions (Tracks 1 & 2) from 8:10 AM to 11:30 AM

  • Exhibit Hall Show Hours: 9:45AM-7:15PM

  • Networking Break & Technology Showcase from 9:45 AM to 10:30 AM

  • Scientific Briefings from 12:05 PM to 12:35 PM

  • Networking Luncheon at 1:05 PM

  • Afternoon Sessions (Tracks 1 & 2) from 2:25 PM to 5:45 PM

  • Exhibit Hall Networking Reception from 6:15 PM to 7:15 PM

Day 4: Wednesday, December 17, 2025

  • Sunrise Yoga at 6:30 AM

  • Registration at 7:15 AM

  • Scientific Breakfast Briefings at 7:30 AM

  • Exhibit Hall Show Hours: 9:45AM-2:10PM

  • Morning Sessions (Tracks 1 & 2) from 8:10 AM to 11:30 AM

  • Networking Break & Poster Viewing from 9:45 AM to 10:30 AM

  • Scientific Briefings at 12:00 PM

  • Networking Luncheon at 12:30 PM

  • Afternoon Sessions (Tracks 1 & 2) from 2:10 PM to 5:45 PM

  • Close of Conference at 5:45 PM

About KACTUS

KACTUS excels in crafting and producing an array of superior-grade, highly active recombinant proteins and enzymes, catering to diverse sectors like antibody drug discovery, immunotherapy, gene therapy, and mRNA therapeutics. Our expansive catalog, boasting over 2500 recombinant proteins, encompasses a wide spectrum of targets, species, tags, and labels, each thoughtfully chosen to address the specific, unmet needs of scientists engaged in drug development. The hallmark of our product selection process is a rigorous emphasis on exceptional quality and a steadfast commitment to ensuring reliable supply, thereby upholding the highest standards of excellence and client satisfaction.

Featured Products 

MHC Monomers & Tetramers

VLP-Displayed Antigens

 

Latest Posts
CDCP1: A New Therapeutic Target for Malignant Tumors
IgE:  The Key Therapeutic Target for Allergy Treatment
CDH17: The Next Breakthrough in Gastrointestinal Cancer Therapy